Restructuring in U.S. trims Kodak sales
Eastman Kodak reporteda 3% decline in revenue last week for its Health Group, whichincludes x-ray film, electronic imaging products and SterlingWinthrop contrast agents, as well as the nonimaging Sterling pharmaceuticalbusiness. X-ray products gained in
Eastman Kodak reporteda 3% decline in revenue last week for its Health Group, whichincludes x-ray film, electronic imaging products and SterlingWinthrop contrast agents, as well as the nonimaging Sterling pharmaceuticalbusiness. X-ray products gained in volume for the period, Kodaksaid. Overall revenues at the film giant were up 1% for the firstquarter (end-March).
Kodak attributed its Health Group's weak performance to theongoing restructuring in U.S. health-care markets. Total HealthGroup revenues dropped to $1.2 billion in the first quarter of1994, from $1.25 in the same period of last year. Revenue in theinternational segment of Kodak's Health Group actually rose 5%,while U.S. revenue was down 9%.
Health Group earnings from operations rose 17% for the quarterfrom $118 million in 1993 to $138 million. This rise in operatingearnings was the lowest of Kodak's three industry segments ofImaging (general photographic), Information and Health. Kodak'stotal worldwide revenue in the first quarter was $3.6 billion.
FDA Clears Virtually Helium-Free 1.5T MRI System from Siemens Healthineers
June 26th 2025Offering a cost- and resource-saving DryCool magnet technology, the Magnetom Flow.Ace MRI system reportedly requires 0.7 liters of liquid helium for cooling over the lifetime of the device in contrast to over 1,000 liters commonly utilized with conventional MRI platforms.
